The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Interclox DC Intramammary Suspension

500, 250
mg/syringe Intramammary suspension


Chem-PharmVPA10823/011/001

Main Information

Trade NameInterclox DC Intramammary Suspension
Active SubstancesCloxacillin
Ampicillin
Strength500, 250
mg/syringe
Dosage FormIntramammary suspension
Licence HolderChem-Pharm
Licence NumberVPA10823/011/001

Group Information

ATC CodeQJ51RC Beta-lactam antibacterials, penicillins, combinations with other antibacterials
Therapeutic ClassAntibacterial
SpeciesCattle

Status

Authorised/WithdrawnAuthorised
Licence Issued01/10/1999
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back